11-Year-Old With Bardet‑Biedl Syndrome Becomes Second Person Worldwide To Receive Novel BBS10 Retinal Gene Therapy

An 11-year-old London girl with Bardet‑Biedl syndrome became the second person worldwide and the first in the U.K. to receive an experimental retinal gene therapy targeting BBS10 mutations. The March procedure ...



























